Cargando…

Virus-Specific T Cells for the Immunocompromised Patient

While progress has been made in the treatment of both hematologic cancers and solid tumors, chemorefractory or relapsed disease often portends a dismal prognosis, and salvage chemotherapy or radiation expose patients to intolerable toxicities and may not be effective. Hematopoietic stem cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houghtelin, Amy, Bollard, Catherine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641550/ https://www.ncbi.nlm.nih.gov/pubmed/29075259 http://dx.doi.org/10.3389/fimmu.2017.01272

Ejemplares similares

Adoptive T Cell Therapy for Epstein–Barr Virus Complications in Patients With Primary Immunodeficiency Disorders
por: McLaughlin, Lauren P., et al.
Publicado: (2018)

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
por: Harris, Katherine M., et al.
Publicado: (2020)

“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients
por: Koukoulias, Kiriakos, et al.
Publicado: (2021)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

The Role of Microbiota and Immunobiotics in Granulopoiesis of Immunocompromised Hosts
por: Salva, Susana, et al.
Publicado: (2017)

B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review
por: Diks, Annieck M., et al.
Publicado: (2021)

Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders
por: Patel, Shabnum, et al.
Publicado: (2019)

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)

Editorial: Immune intervention avenues to control fungal infections in immunocompromised individuals
por: Nanjappa, Som G.
Publicado: (2023)

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care
por: Saglio, Francesco, et al.
Publicado: (2014)

Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients
por: Ameratunga, Rohan, et al.
Publicado: (2022)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients
por: Bader, Guy, et al.
Publicado: (2023)

Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response
por: Agrati, Chiara, et al.
Publicado: (2023)

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
por: Paramithiotis, Eustache, et al.
Publicado: (2022)

Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation
por: Lee, Ping-Hsien, et al.
Publicado: (2020)

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

Mechanism of the Immunomodulatory Effect of the Combination of Live Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus on Immunocompromised Rats
por: Lv, Longxian, et al.
Publicado: (2021)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
por: Mahdi, Jasia, et al.
Publicado: (2021)

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates
por: Dross, Sandra, et al.
Publicado: (2023)

CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients
por: Schulz, Eduard, et al.
Publicado: (2021)

Specific Adoptive T-Cell Therapy for Viral and Fungal Infections
por: Lum, Lawrence G., et al.
Publicado: (2018)

West Nile virus encephalomyelitis in an immunocompromised patient
por: Eid, Abdulmunaim M., et al.
Publicado: (2023)

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
por: Baron, Frédéric, et al.
Publicado: (2022)

Flagellin/NLRC4 Pathway Rescues NLRP3-Inflammasome Defect in Dendritic Cells From HIV-Infected Patients: Perspective for New Adjuvant in Immunocompromised Individuals
por: dos Reis, Edione Cristina, et al.
Publicado: (2019)

Succinylation modification provides new insights for the treatment of immunocompromised individuals with drug-resistant Aspergillus fumigatus infection
por: Chen, Xianzhen, et al.
Publicado: (2023)

The impact of immunocompromise on outcomes of COVID-19 in children and young people—a systematic review and meta-analysis
por: Greenan-Barrett, James, et al.
Publicado: (2023)

Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA
por: Carlson, Abigail L., et al.
Publicado: (2018)

Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group
por: Kim, Kangsan, et al.
Publicado: (2022)

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
por: Chu, Chang, et al.
Publicado: (2023)

Atypical Chikungunya Virus Infections in Immunocompromised Patients
por: Kee, Adrian C.L., et al.
Publicado: (2010)

Integrated multi-omics analyses reveal the altered transcriptomic characteristics of pulmonary macrophages in immunocompromised hosts with Pneumocystis pneumonia
por: Wang, Yawen, et al.
Publicado: (2023)

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
por: Du, Yue, et al.
Publicado: (2022)

Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis
por: Xia, Yue, et al.
Publicado: (2022)

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
por: Rescigno, Maria, et al.
Publicado: (2023)

Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection
por: Koblischke, Maximilian, et al.
Publicado: (2018)

SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
por: Conway, Susan R., et al.
Publicado: (2022)

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells
por: Baker, Forrest L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knmt3u4srt71t19ejggphdrnlc